Phase II Confirmatory Study in Erythropoietic Protoporphyria (EPP)

NCT01097044 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

77

Enrollment

INDUSTRY

Sponsor class

Conditions

Erythropoietic Protoporphyria

Interventions

DRUG: Afamelanotide
DRUG: Placebo

Sponsor

Clinuvel Pharmaceuticals Limited